It appears that your browser has JavaScript disabled.

This Website requires your browser to be JavaScript enabled.

Please enable JavaScript and reload this page.

multiple+sclerosis

231 Results Advanced Search

Documents (202)

Site Content (14)

Can't Find What You're Looking For?

Contact Customer Service

Press Release: 150 Cyclists from EMD Millipore and EMD Serono Participated in 150 Mile Ride for MS
MilliporeSigma participates in and sponsor the Bike MS: Cape Cod Getaway ride to raise money for Multiple Sclerosis (MS).
Neuroscience Multiplex Assays Using Luminex® Technology | Life Science Research | MilliporeSigma
Our neuroscience multiplex assays reveal the roles of biomarkers in normal and disease states, in the study of neurological disorders like Parkinson's and ALS.
Neuroscience Antibodies & Assays | Life Science Research | MilliporeSigma
We have been commited to creating a validated collection of neuroscience antibodies and assays for studying development, differentiation, and disorders in the nervous system
Neurodegenerative Diseases | Life Science Research | MilliporeSigma
Neurodegenerative diseases are characterized by deterioration of neurons or their myelin sheath, disrupting transmission of sensory information, movement control, and more.
Histone Modifications | Epigenetics - Life Science Research | EMD Millipore
Histone modifications regulate DNA transcription, repair, recombination, and replication, and can alter local chromatin architecture. Understanding histone modifications is key to uncovering epigenetic mechanisms of gene regulation. MilliporeSigma grasps the complexity of this research and provides a growing line of kits, antibodies, and assays for studying histones and their modifications. MilliporeSigma offers over 600 validated antibodies, recombinant proteins, and kits to analyze histone and histone-variant phosphorylation, methylation, acetylation, ubiquitination, and citrullination-the most widely studied histone modifications in epigenetics today.
Press Release: Merck KGaA, Darmstadt, Germany, to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry
Merck KGaA, Darmstadt, Germany, today announced that they have entered into a definitive agreement under which Merck KGaA, Darmstadt, Germany, will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry.
Press Release: MilliporeSigma Donates to American Red Cross to Support Greater St. Louis Flood Victims
MilliporeSigma today announced it has donated $10,000 to the American Red Cross of the Greater St. Louis Region in support of the organization's flood relief efforts.
Press Release: Merck KGaA, Darmstadt, Germany's Massachusetts-based Business Sectors Named 'Top Place to Work' by The Boston Globe
Merck KGaA, Darmstadt, Germany today announced that its Massachusetts-based business sectors, EMD Serono and MilliporeSigma, have been named to The Boston Globe's annual "Top Places to Work" list for the second year in a row.
Press Release: Merck KGaA, Darmstadt, Germany Launches Innovative System for Monitoring T cells in HIV patients in Nigeria
Merck KGaA, Darmstadt, Germany today announced the launch of its innovative Muse® Auto CD4/CD4% System, a portable instrument for monitoring T cells and CD4 counts in HIV affected patients in Nigeria.
Press Release: Merck KGaA, Darmstadt, Germany Supports Next Generation of Scientists at USA Science & Engineering Festival
Merck KGaA, Darmstadt, Germany, today announced that it is participating in the 4th USA Science & Engineering Festival (USASEF), April 16-17, 2016 in Washington D.C.